2026 John M. Kane: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	165	636	582	365	327	1165	99861

John M. Kane publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John M. Kane sits on this spectrum.

101 publications 1,796+

This scientist: 1,165 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John M. Kane D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John M. Kane sits on this spectrum.

70 D-Index 217+

This scientist: 165 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John M. Kane is affiliated with Zucker Hillside Hospital in the United States. Their research spans extensively across medicine and psychology, with a primary focus on psychiatry and mental health. This includes significant work in clinical psychology, philosophy, experimental and cognitive psychology, and pharmacology.

The main topics of their research include:

Schizophrenia research and treatment
Bipolar Disorder and Treatment
Mental Health and Psychiatry
Mental Health Research Topics
Digital Mental Health Interventions
Tryptophan and brain disorders
Mental Health Treatment and Access

John M. Kane frequently publishes in a range of psychiatric and neuroscience journals. The venues with the highest number of publications include:

Schizophrenia Bulletin
UNC Libraries
Schizophrenia Research
Schizophrenia
The Lancet Psychiatry

Some of their recent papers include:

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research, 2020, Schizophrenia
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies, 2021, The Lancet Psychiatry
Efficacy and Safety of Lumateperone for Treatment of Schizophrenia, 2020, JAMA Psychiatry
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels, 2021, Pharmacopsychiatry
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia, 2020, JAMA Psychiatry

Among frequent co-authors collaborating with John M. Kane are Christoph U. Correll, José M. Rubio, Georgios Schoretsanitis, Daniel Guinart, and Patricia Marcy. These partnerships illustrate ongoing engagement in multidisciplinary and clinical research communities.

Best Publications

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

John Kane;Gilbert Honigfeld;Jack Singer;Herbert Meltzer

5399
Citations
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus

Nancy C. Andreasen;William T. Carpenter;John M. Kane;Robert A. Lasser

3082
Citations
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Janet B. W. Williams;Miriam Gibbon;Michael B. First;Robert L. Spitzer

2074
Citations
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

Herbert Y. Meltzer;Larry Alphs;Alan I. Green;A. Carlo Altamura

1736
Citations
What does the PANSS mean

Stefan Leucht;Stefan Leucht;John M. Kane;Werner Kissling;Johannes Hamann

1524
Citations
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges

John M. Kane

1523
Citations
Research diagnoses for tardive dyskinesia.

Nina R. Schooler;John M. Kane

1301
Citations
Practice guideline for the treatment of patients with schizophrenia

M. I. Herz;R. P. Liberman;T. H. McGlashan;J. A. Lieberman

1278
Citations
Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

Robert M. Bilder;Robert S. Goldman;Delbert Robinson;Gail Reiter

1267
Citations
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Christoph U. Correll;Peter Manu;Vladimir Olshanskiy;Barbara Napolitano

1215
Citations
Physical Health Monitoring of Patients With Schizophrenia

Stephen R. Marder;Susan M. Essock;Alexander L. Miller;Robert W. Buchanan

1139
Citations
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Oliver D. Howes;Rob McCutcheon;Ofer Agid;Andrea De Bartolomeis

1097
Citations
Tardive dyskinesia: prevalence and risk factors, 1959 to 1979

John M. Kane;James M. Smith

951
Citations
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

John M Kane;William H Carson;Anutosh R Saha;Robert D McQuade

948
Citations
Clinical implications of Brief Psychiatric Rating Scale scores.

Stefan Leucht;John M. Kane;Werner Kissling;Johannes Hamann

932
Citations
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

John M. Kane;Delbert G. Robinson;Nina R. Schooler;Kim T. Mueser

904
Citations
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Christoph U. Correll;Stefan Leucht;John M. Kane

900
Citations
The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). II: Multi-site test-retest reliability study

Michael B. First;Robert L. Spitzer;Miriam Gibbon;Janet B.W. Williams

840
Citations
Provocative tests with psychostimulant drugs in schizophrenia.

J A Lieberman;J A Lieberman;J M Kane;J M Kane;J Alvir

750
Citations
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

Stefan Leucht;Thomas R.E. Barnes;Werner Kissling;Rolf R. Engel

705
Citations

Frequent Co-Authors

Christoph U. Correll Charité - University Medicine Berlin

Anil K. Malhotra Hofstra University

Jeffrey A. Lieberman Columbia University

Delbert G. Robinson Feinstein Institute for Medical Research

Stefan Leucht Technical University of Munich

Todd Lencz Feinstein Institute for Medical Research

Stephen R. Marder University of California, Los Angeles

W. Wolfgang Fleischhacker Innsbruck Medical University

Kim T. Mueser Boston University

Robert M. Bilder University of California, Los Angeles

External Links

Personal website of John M. Kane

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean taking the traditional path to becoming a doctor. There are several online degrees and career pathways in healthcare that offer flexibility and allow you to enter the workforce sooner.

For example, those interested in nursing can consider fast track medical lpn programs online. These programs provide a quicker route to become a Licensed Practical Nurse, helping you start your patient care career in as little as 12 months.

For advanced practice and mental health specialization, explore the fastest post master's pmhnp online options. These accelerated Psychiatric Mental Health Nurse Practitioner programs are great for nurses who want to deepen their expertise and career prospects.

Interested in healthcare leadership? A healthcare administration degree online can open doors to management positions in hospitals and clinics. Many institutions also offer affordable mha online programs for those seeking a master's degree. These options are ideal for individuals who want to manage and improve healthcare delivery.